Cancer Family
Nervous System Neoplasm
CI-CAN-00000038Explore in graph →
Non-malignant1,523 active trials9 approved drugs210 evidence items
Loading cancer entity…
Cancer Family
CI-CAN-00000038Explore in graph →
Clinical trials
5,871 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT04650204 | Perampanel for the Reduction of Seizure Frequency in Patients With High-grade Glioma and Focal Epilepsy | terminated | Phase 4 | 4 | Mayo ClinicOTHER | 1 | Jun 22, 2023 | clinicaltrials |
| NCT02028325 | Yellow 560 Microscope for Intraoperative Visualization of Fluorescein Stained Intracranial Lesions(Fluorescein) | terminated | Phase 4 | 136 | Indiana UniversityOTHER | 1 | Nov 8, 2016 | clinicaltrials |
| NCT01756729 | Post-approval Study of NovoTTF-100A in Recurrent GBM Patients | terminated | Phase 4 | 13 | NovoCure Ltd.INDUSTRY | 1 | Mar 2, 2016 | clinicaltrials |
| NCT00415467 | Treatment of Resectable Malignant Brain Tumors | terminated | Phase 4 | 13 | M.D. Anderson Cancer CenterOTHER | 1 | Aug 2, 2012 | clinicaltrials |
Data updated 22 days agoSource updated Jun 22, 2023source: clinicaltrials